CCEL
Income statement / Annual
Last year (2023), Cryo-Cell International, Inc.'s total revenue was $31.34 M,
an increase of 3.32% from the previous year.
In 2023, Cryo-Cell International, Inc.'s net income was -$9.52 M.
See Cryo-Cell International, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
11/30/2023 |
11/30/2022 |
11/30/2021 |
11/30/2020 |
11/30/2019 |
11/30/2018 |
11/30/2017 |
11/30/2016 |
11/30/2015 |
11/30/2014 |
| Operating Revenue |
$31.34 M
|
$30.34 M
|
$28.88 M
|
$31.15 M
|
$31.82 M
|
$29.22 M
|
$25.38 M
|
$23.13 M
|
$21.09 M
|
$20.13 M
|
| Cost of Revenue |
$8.44 M |
$8.79 M |
$8.99 M |
$9.66 M |
$10.04 M |
$8.54 M |
$6.72 M |
$5.77 M |
$5.63 M |
$5.63 M |
| Gross Profit |
$22.90 M |
$21.54 M |
$19.90 M |
$21.49 M |
$21.78 M |
$20.68 M |
$18.66 M |
$17.35 M |
$15.46 M |
$14.49 M |
| Gross Profit Ratio |
0.73 |
0.71 |
0.69 |
0.69 |
0.68 |
0.71 |
0.74 |
0.75 |
0.73 |
0.72 |
| Research and Development
Expenses |
$1.17 M
|
$384,789.00
|
$49,870.00
|
$23,851.00
|
$30,145.00
|
$91,845.00
|
$41,165.00
|
$53,097.00
|
$45,780.00
|
$64,367.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$15.63 M
|
$13.48 M
|
$14.72 M
|
$12.39 M
|
$12.25 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$17.12 M
|
$15.58 M
|
$14.63 M
|
$14.29 M
|
$14.89 M
|
$15.63 M
|
$13.48 M
|
$14.72 M
|
$12.39 M
|
$12.25 M
|
| Other Expenses |
$16.92 M |
$1.12 M |
$834,845.00 |
$166,437.00 |
$206,238.00 |
-$24,723.00 |
-$79,873.00 |
-$14,671.00 |
$22,993.00 |
$210,258.00 |
| Operating Expenses |
$35.21 M |
$17.08 M |
$15.51 M |
$14.48 M |
$15.13 M |
$15.90 M |
$13.65 M |
$14.93 M |
$12.53 M |
$12.49 M |
| Cost And Expenses |
$43.65 M |
$25.88 M |
$24.50 M |
$24.14 M |
$25.16 M |
$24.44 M |
$20.38 M |
$20.71 M |
$18.16 M |
$18.12 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$1.24 M |
$1.52 M |
$1.38 M |
$1.54 M |
$1.70 M |
$1.55 M |
$1.30 M |
$947,340.00 |
$1.30 M |
$1.15 M |
| Depreciation &
Amortization |
$1.71 M
|
$1.81 M
|
$1.33 M
|
$635,975.00
|
$401,311.00
|
$317,326.00
|
$229,995.00
|
$286,650.00
|
$241,208.00
|
$377,008.00
|
| EBITDA |
-$10.42 M
|
$6.65 M
|
$5.32 M
|
$7.22 M
|
$5.50 M
|
$5.48 M
|
$5.16 M
|
-$1.25 M
|
$2.49 M
|
$2.21 M
|
| EBITDA Ratio |
-0.33 |
0.21 |
0.2 |
0.25 |
0.22 |
0.17 |
0.2 |
0.12 |
0.15 |
0.11 |
| Operating Income Ratio
|
-0.39
|
0.13
|
0.14
|
0.25
|
0.16
|
0.18
|
0.2
|
0.02
|
0.14
|
0.1
|
| Total Other
Income/Expenses Net |
-$1.06 M
|
-$705,519.00
|
-$1.41 M
|
-$2.62 M
|
-$1.67 M
|
-$1.57 M
|
-$1.38 M
|
-$2.91 M
|
-$1.98 M
|
-$1.30 M
|
| Income Before Tax |
-$13.36 M |
$3.32 M |
$2.61 M |
$5.04 M |
$3.39 M |
$3.62 M |
$3.62 M |
-$2.48 M |
$949,521.00 |
$677,149.00 |
| Income Before Tax Ratio
|
-0.43
|
0.11
|
0.09
|
0.16
|
0.11
|
0.12
|
0.14
|
-0.11
|
0.05
|
0.03
|
| Income Tax Expense |
-$3.84 M |
$547,540.00 |
$527,710.00 |
$1.41 M |
$1.10 M |
$4.47 M |
$1.31 M |
-$1.16 M |
-$7.16 M |
$123,526.00 |
| Net Income |
-$9.52 M |
$2.77 M |
$2.08 M |
$3.62 M |
$2.29 M |
-$854,824.00 |
$2.32 M |
-$1.32 M |
$8.11 M |
$553,623.00 |
| Net Income Ratio |
-0.3 |
0.09 |
0.07 |
0.12 |
0.07 |
-0.03 |
0.09 |
-0.06 |
0.38 |
0.03 |
| EPS |
-1.14 |
0.33 |
0.26 |
0.48 |
0.29 |
-0.11 |
0.33 |
-0.16 |
0.85 |
0.05 |
| EPS Diluted |
-1.14 |
0.33 |
0.25 |
0.45 |
0.27 |
-0.11 |
0.3 |
-0.16 |
0.83 |
0.05 |
| Weighted Average Shares
Out |
$8.34 M
|
$8.47 M
|
$8.14 M
|
$8.14 M
|
$8.41 M
|
$7.46 M
|
$7.06 M
|
$8.11 M
|
$9.54 M
|
$10.18 M
|
| Weighted Average Shares
Out Diluted |
$8.34 M
|
$8.48 M
|
$8.36 M
|
$8.14 M
|
$8.41 M
|
$7.46 M
|
$7.65 M
|
$8.11 M
|
$9.80 M
|
$10.43 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
